Literature DB >> 9472999

Respiratory syncytial virus pneumonitis-induced diffuse alveolar damage in an autologous bone marrow transplant recipient.

S N Markovic1, A Adlakha, T F Smith, R C Walker.   

Abstract

A 24-year-old woman with recurrent Hodgkin's lymphoma, stage IIB nodular sclerosing type, underwent an autologous bone marrow transplantation. Forty-five days after transplantation, an upper respiratory tract infection developed that progressed to respiratory distress necessitating mechanical ventilation. An open-lung biopsy demonstrated diffuse alveolar damage. After an extensive search for the cause of the respiratory compromise, we detected respiratory syncytial virus in a bronchoalveolar lavage specimen. The patient was immediately treated with aerosolized ribavirin and intravenous immunoglobulin; her symptoms resolved, and she was extubated 4 days after initiation of therapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472999     DOI: 10.1016/S0025-6196(11)63648-3

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  3 in total

Review 1.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

2.  Successful treatment of parainfluenza virus 3 pneumonia with oral ribavirin and methylprednisolone in a bone marrow transplant recipient.

Authors:  Takahiro Shima; Goichi Yoshimoto; Atsushi Nonami; Shuro Yoshida; Kenjiro Kamezaki; Hiromi Iwasaki; Katsuto Takenaka; Toshihiro Miyamoto; Naoki Harada; Takanori Teshima; Koichi Akashi; Koji Nagafuji
Journal:  Int J Hematol       Date:  2008-08-19       Impact factor: 2.490

Review 3.  Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies.

Authors:  Fareed Khawaja; Roy F Chemaly
Journal:  Haematologica       Date:  2019-06-20       Impact factor: 9.941

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.